Characterization of the Anti-Viral and Vaccine-Specific CD8
CD8+ T cell effector phenotype
VSV-GP
cancer vaccine vector
heterologous cancer vaccination
memory-precursor effector cells (MPECs)
route of vaccination
short-lived effector cells (SLECs)
vaccination dose
vaccine regime design
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
01 Aug 2024
01 Aug 2024
Historique:
received:
01
06
2024
revised:
18
07
2024
accepted:
25
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Numerous factors influence the magnitude and effector phenotype of vaccine-induced CD8
Identifiants
pubmed: 39203993
pii: vaccines12080867
doi: 10.3390/vaccines12080867
pmc: PMC11359161
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Austrian Research Promotion Agency
ID : 877143
Organisme : Christian Doppler Research Association
ID : n.a.
Références
Science. 2010 Feb 5;327(5966):689-93
pubmed: 20133572
Age (Dordr). 2009 Dec;31(4):285-91
pubmed: 19479342
Nat Cancer. 2022 Feb;3(2):143-155
pubmed: 35228747
J Virol. 2014 May;88(9):4897-907
pubmed: 24554655
Viruses. 2019 Feb 15;11(2):
pubmed: 30769947
Signal Transduct Target Ther. 2023 Jun 19;8(1):235
pubmed: 37332039
Cell. 2022 Jul 21;185(15):2770-2788
pubmed: 35835100
Mol Ther Methods Clin Dev. 2022 Dec 28;28:190-207
pubmed: 36700123
Cancers (Basel). 2021 Dec 03;13(23):
pubmed: 34885215
Cancer Res. 2014 Jun 1;74(11):2974-85
pubmed: 24728077
Nat Commun. 2021 Sep 1;12(1):5217
pubmed: 34471116
J Immunol. 2018 Jun 1;200(11):3752-3761
pubmed: 29669782
Nat Immunol. 2011 Nov 20;13(1):51-7
pubmed: 22101728
J Virol. 2011 Dec;85(23):12160-9
pubmed: 21917977
Nature. 2018 May;557(7706):575-579
pubmed: 29769722
Nature. 2007 Nov 1;450(7166):110-4
pubmed: 17934446
Immunity. 2018 Apr 17;48(4):716-729.e8
pubmed: 29625895
J Immunol. 2012 Oct 1;189(7):3397-403
pubmed: 22914049
Mol Ther. 2011 Jan;19(1):150-8
pubmed: 20959810
J Virol. 2012 Apr;86(8):4253-61
pubmed: 22345454
Cell Rep. 2020 Mar 24;30(12):3964-3971.e7
pubmed: 32209459
J Immunol. 2006 Jul 15;177(2):831-9
pubmed: 16818737
J Immunol. 2005 Apr 15;174(8):4465-9
pubmed: 15814665
Nat Commun. 2021 Aug 31;12(1):5195
pubmed: 34465781
Nat Rev Immunol. 2019 Feb;19(2):89-103
pubmed: 30464294
Future Oncol. 2022 Aug;18(24):2627-2638
pubmed: 35699077
Cancer Res. 2014 Jul 1;74(13):3567-78
pubmed: 24812275
Immunity. 2007 Aug;27(2):281-95
pubmed: 17723218
Vaccines (Basel). 2019 Jul 03;7(3):
pubmed: 31277325
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
J Immunol. 2002 Oct 1;169(7):3760-70
pubmed: 12244170
Eur J Immunol. 2019 May;49(5):694-708
pubmed: 30883723
EBioMedicine. 2017 May;19:107-118
pubmed: 28434944
Curr Opin Immunol. 2003 Feb;15(1):120-7
pubmed: 12495743
Nat Immunol. 2003 Dec;4(12):1191-8
pubmed: 14625547
Proc Natl Acad Sci U S A. 1976 May;73(5):1504-8
pubmed: 179088
J Immunol. 1999 Oct 1;163(7):3735-45
pubmed: 10490969
Pharm Res. 2019 Dec 23;37(1):12
pubmed: 31873819
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):216-21
pubmed: 20018690
Immunity. 2007 Jun;26(6):827-41
pubmed: 17555991
Nat Immunol. 2021 Jan;22(1):41-52
pubmed: 33139915
Oncoimmunology. 2013 Jan 1;2(1):e22616
pubmed: 23482345
Viruses. 2018 Mar 02;10(3):
pubmed: 29498639
Br J Cancer. 2019 Oct;121(8):647-658
pubmed: 31530903
Semin Immunopathol. 2019 Jan;41(1):69-85
pubmed: 29978248
J Gen Virol. 2017 Dec;98(12):2895-2911
pubmed: 29143726
Sci Rep. 2015 Jul 20;5:12264
pubmed: 26191658
Front Immunol. 2020 Jan 08;10:3016
pubmed: 31969886
J Immunol. 2011 Nov 15;187(10):4967-78
pubmed: 21987662
Cell Rep. 2017 Nov 28;21(9):2515-2527
pubmed: 29186688
Leukemia. 2023 Mar;37(3):606-616
pubmed: 36658390
Semin Immunol. 2012 Jun;24(3):209-17
pubmed: 22551764
Nature. 2021 Aug;596(7870):119-125
pubmed: 34290406
J Immunol. 2002 May 1;168(9):4391-8
pubmed: 11970981
Pathogens. 2021 Aug 27;10(9):
pubmed: 34578125
Cancer Immunol Immunother. 2019 Mar;68(3):455-466
pubmed: 30604041